How Optic Neuritis Diagnosis Has Evolved Over the Years – Dr. Nilüfer Kale

Living With HS: Tamika Carter’s Journey to Diagnosis and Treatment

Understanding Alzheimer’s Disease: Biomarkers and Early Detection with Dr. Rudy Castellani

What Causes Optic Neuritis to Progress — And Can We Stop It? – Dr. Nilüfer Kale

How MRI Lesions and Oligoclonal Bands Predict MS Conversion – Dr. Nilüfer Kale

When to Use Steroids in Optic Neuritis Evidence Based Insights – Dr. Nilüfer Kale

Managing Optic Neuritis: Steroids, Plasma Exchange, And IVIG Decisions Explained – Dr. Nilüfer Kale

Can PET Scans Reveal Hidden Inflammation in MS? Emerging Insights – Dr. Nilüfer Kale

The Realities of MS Treatment Access and Global Disparities – Dr. Nilüfer Kale

Treatment Decisions in Optic Neuritis: MS or MOGAD? – Dr. Nilüfer Kale

Designing Fair And Representative Clinical Trials For Future Oncology Care – Dr. Frank Weinberg

Why Public Understanding of Cancer Research Still Falls Short – Dr. Aruna Anupindi

Media Influence & Clinical Trial Misunderstandings in Cancer Care – Dr. Aruna Anupindi

Why Clinical Trial Representation Matters in Oncology – Dr. Aruna Anupindi

Breaking Cultural Barriers in Accessing Cancer Support – Dr Aruna Anupindi

The Next Wave Of Immune Targeted Cancer Treatments – Dr. Frank Weinberg

How AI Is Transforming Oncology & Clinical Workflows – Dr. Aruna Anupindi

New Approaches to Treating Hormone Resistant Breast Cancer – Dr. Aruna Anupindi

Improving Global Access to Cancer Treatments – Dr. Aruna Anupindi

Emerging Trends in Hormone Receptor Positive Breast Cancer – Dr. Aruna Anupindi

Why Breast Cancer in Young Adults Can Be More Aggressive – Dr. Aruna Anupindi

Why Lung Cancer Is More Aggressive In Younger Patients – Dr. Frank Weinberg

Addressing Cancer Misconceptions in Minority Communities – Dr. Aruna Anupindi

How Cancer Awareness Is Changing Patient Demographics – Dr. Aruna Anupindi

Closing the Gender Gap in Clinical Trials and Oncology Research – Dr. Sherene Loi

The Truth About Breastfeeding, Pregnancy, and Breast Cancer Risk – Dr. Sherene Loi

What Surprised Researchers About the Immune Impact of Pregnancy – Dr. Sherene Loi

The Next Frontier in Breast Cancer Detection and Prevention – Dr. Sherene Loi

Making Breast Cancer Prevention Affordable and Accessible Worldwide – Dr. Sherene Loi

Can Reproductive History Influence Response to Immunotherapy? – Dr. Sherene Loi

82 5% of Breast Cancer Survivors Experience PTSD Symptoms

How Pregnancy Inspired Immunotherapy Could Prevent Breast Cancer – Dr. Sherene Loi

Why Pregnancy Protects Against Breast Cancer Even in High Risk Women – Dr. Sherene Loi

How AI Agents and Digital Twins Could Redefine Cancer Care – Dr Marcella Prelaj

How Pregnancy and Breastfeeding Protect Against Triple Negative Breast Cancer – Dr. Sherene Loy

Addressing Bias in AI Models for Cancer Research and Clinical Decision-Making – Dr. Marcella Prelaj

Using Synthetic Data to Improve Representation in Medical Research – Dr. Marcella Prelaj

Can AI Really Keep Medical Data Clean and Reliable? – Dr. Marcella Prelaj

Innovation, Access, and the Future of Cardiac Care ft. Dr. Quentin Youmans

Synthetic Data and the Push to Democratize Healthcare Research – Dr. Marcella Prelaj

AI Tools Helping Patients Find and Join the Right Clinical Trials – Dr. Marcella Prelaj

Why Doctors and Researchers Must Learn AI to Stay Ahead – Dr. Marcella Prelaj

Why AI Is Redefining How We Predict Clinical Trial Success – Dr. Marcella Prelai

From Awareness to Action: Dr. Aruna Anupindi on Cancer Prevention and Patient Empowerment

How Parity and Breastfeeding May Guard Against Triple-Negative Breast Cancer Ft. Dr. Sherene Loi

How AI Is Transforming Clinical Trial Design and Cancer Research – Dr. Arsela Prelaj

The Hidden Causes of Lung Cancer Beyond Smoking – Dr. Frank Weinberg

What It Feels Like to See Your Scars After Cancer

How Autoimmune Diseases Affect Lung Cancer Treatment Decisions – Dr. Frank Weinberg

Using Education Materials To Improve Patient Understanding In Lung Cancer Care – Dr. Frank Weinberg

Helping Patients Understand MS Biomarkers and Take Control of Their Care – Dr. Ahmed Abdelhak

What Clinicians Should Know About Interpreting MS Biomarkers – Dr. Ahmed Abdelhak

Using Biomarker Trajectories to Predict MS Progression and Treatment Response – Dr. Ahmed Abdelhak

Gene Editing and Multiple Sclerosis: How Close Are We Really? – Dr. Ahmed Abdelhak

The Overlooked Cells That Could Transform MS Treatment – Dr. Ahmed Abdelhak

Combining Fluid, Imaging, and Genetic Data to Advance MS Progression Monitoring – Dr. Ahmed Abdelhak

How Age, Sex, and BMI Affect Biomarker Interpretation in MS – Dr. Ahmed Abdelhak

Cross Specialty Collaboration in Multiple Sclerosis Research – Dr. Ahmed Abdelhak

How Patient Communication Builds Trust In Lung Cancer Treatment – Dr. Frank Weinberg

Why Every Lung Cancer Patient Deserves Comprehensive Molecular Testing – Dr. Frank Weinberg